Quick Answer
KYNTRA BIO, INC. reported Net Income of $183.45 million for fiscal year 2025.
KYNTRA BIO, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $183.45M | +485.6% |
| 2024 | -$47.58M | +83.3% |
| 2023 | -$284.23M | +3.2% |
| 2022 | -$293.65M | -1.3% |
| 2021 | -$290.02M | -53.2% |
| 2020 | -$189.29M | -145.9% |
| 2019 | -$76.97M | +10.9% |
| 2018 | -$86.42M | +28.5% |
| 2017 | -$120.88M | -108.2% |
| 2016 | -$58.07M | +32.3% |
| 2015 | -$85.78M | -44.2% |
| 2014 | -$59.50M | -298.2% |
| 2013 | -$14.94M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $200.64M | +1274.4% | +2738.9% |
| June 30, 2025 | -$7.60M | +51.1% | -263.9% |
| March 31, 2025 | $4.64M | +114.1% | +127.2% |
| September 30, 2024 | -$17.08M | +73.1% | -9.9% |
| June 30, 2024 | -$15.54M | +82.3% | +52.8% |
| March 31, 2024 | -$32.93M | +57.1% | +48.2% |
| September 30, 2023 | -$63.62M | +30.6% | +27.4% |
| June 30, 2023 | -$87.68M | -20.7% | -14.3% |
- KYNTRA BIO, INC. showed an increase of +485.6% in Net Income compared to the prior fiscal year.
- Over the 2013–2025 period, KYNTRA BIO, INC.’s net income has grown by 1327.7% (from -$14.94 million to $183.45 million).
- The most recent figure is from KYNTRA BIO, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: